A 510(k) predicate device is a legally marketed medical device used as the basis for comparison in an FDA Premarket Notification. The manufacturer must demonstrate that the new device is substantially equivalent to the predicate in intended use, technological characteristics, safety and effectiveness.
A strong predicate is not simply a similar product. It must provide a scientifically and legally defensible foundation for the entire 510(k) submission.
What Is a 510(k) Predicate Device?
The FDA 510(k) premarket notification pathway allows an eligible medical device to reach the US market by demonstrating substantial equivalence to an existing legally marketed device.
A predicate may be:
- A device previously cleared through the 510(k) pathway
- A device legally marketed before May 28, 1976
- A device originally regulated as Class III and subsequently reclassified
- An eligible 510(k)-exempt device
The predicate does not need to be manufactured by the same company or remain commercially available. However, it must have been legally marketed and should provide an appropriate comparison for the new device.
What Does Substantial Equivalence Mean?
Substantial equivalence does not mean that the devices must be identical. The new device must have:
- The same intended use as the predicate; and
- The same technological characteristics; or
- Different technological characteristics that do not raise different questions of safety and effectiveness
When technological differences exist, manufacturers must provide sufficient evidence showing that the new device is at least as safe and effective as the predicate.
The comparison may address:
- Indications for use and target population
- Anatomical site and use environment
- Device design and operating principles
- Materials and patient-contacting components
- Energy delivered or received
- Software and cybersecurity features
- Sterility and packaging
- Biocompatibility
- Electrical and mechanical safety
- Performance specifications
- Labelling and human factors
Why Predicate Selection Matters
Predicate selection influences the regulatory strategy, testing requirements, development timeline and probability of clearance. A poorly matched predicate may result in extensive FDA questions or a Not Substantially Equivalent decision.
The predicate should therefore be evaluated before design freeze. Identifying important technological differences early allows the team to incorporate the necessary testing into its development and phase-gate process.
A recently cleared device is often useful because it may better represent current technology and FDA expectations. However, clearance date alone does not make a device suitable. Intended use and technological comparability remain the primary considerations.
How to Select a Predicate Device
1. Confirm the Regulatory Classification
Search the FDA Product Classification Database to identify the device regulation number, product code, class and applicable submission requirements.
Devices with the same product code may be useful candidates, but sharing a product code does not automatically establish substantial equivalence.
2. Search for Legally Marketed Devices
Review the FDA 510(k) database, decision summaries, clearance letters and publicly available labelling. Search by product code, technology, manufacturer and device name.
The primary predicate should be the device most similar to the proposed product in indications for use and technological characteristics.
3. Compare Intended Use
Compare the intended medical purpose, patient population, disease or condition, anatomical site, intended user and use environment.
A significant difference in intended use may prevent the use of the 510(k) pathway, even when the two devices have similar technical designs.
4. Compare Technological Characteristics
Prepare a side-by-side comparison covering design, materials, energy source, operating principle, software, performance specifications and safety features.
Software-enabled devices may require lifecycle evidence aligned with IEC 62304, while electrical medical devices may require safety and performance testing against the applicable IEC 60601 standards.
5. Assess Safety and Performance Differences
Every difference should be evaluated to determine whether it creates a new question of safety or effectiveness. The assessment should connect with the device’s risk-management activities and benefit-risk determination.
Differences may need to be addressed through:
- Bench and functional performance testing
- Electrical safety and EMC testing
- Biocompatibility testing
- Software verification
- Usability or simulated-use studies
- Animal testing
- Clinical evidence, when necessary
The required evidence should be planned within the device’s verification and validation strategy.
Can Multiple Predicate Devices Be Used?
FDA permits more than one predicate in appropriate circumstances. However, the submission should identify a primary predicate with the most similar intended use and technological characteristics.
A manufacturer should not use one device to establish intended use and an unrelated device to establish technological characteristics. This approach is known as a split predicate and is inconsistent with the FDA’s substantial-equivalence standard.
Reference devices may be used to support test methods, scientific principles or specific technical information, but they do not replace the primary predicate.
What Happens If No Suitable Predicate Exists?
If no legally marketed device provides an appropriate comparison, the 510(k) pathway may not be available.
A novel low- or moderate-risk device may qualify for De Novo classification. Higher-risk devices may require Premarket Approval. The correct pathway depends on the device’s risks, intended use and technological characteristics.
Early input from Quality Assurance and Regulatory Affairs specialists can prevent a development team from building its submission around an unsuitable predicate.
Common Predicate-Selection Mistakes
Common problems include:
- Selecting a device based only on physical similarity
- Overlooking differences in indications or use environment
- Using outdated or incomplete public information
- Ignoring recalls and known safety concerns
- Combining unrelated devices as a split predicate
- Underestimating the testing required for technological differences
- Choosing the predicate after verification testing is complete
- Making performance claims unsupported by comparison data
The selection rationale and supporting evidence should be maintained within the regulatory submission and relevant design documentation.
How SJML Supports 510(k) Predicate Strategy
SJML provides medical device compliance services covering regulatory pathway assessment, device classification, predicate research, substantial-equivalence strategy and 510(k) submission preparation.
Its integrated design and engineering capabilities help translate identified predicate differences into design requirements, risk controls and appropriate testing. In-house support for electrical safety, EMC, software, reliability and performance testing helps keep the engineering evidence aligned with the regulatory strategy.
Contact SJML to discuss predicate selection or support for an upcoming 510(k) submission.
Frequently asked questions
A valid predicate is a legally marketed device with the same intended use as the new device, and either equivalent technological characteristics or differences that do not raise new questions of safety and effectiveness. It must have reached the market lawfully, through prior 510(k) clearance, pre-1976 status, or down-classification, and should not be under an unresolved safety recall.
Yes. A submission can cite multiple predicates, often a primary predicate plus additional ones, when a single device does not cover every feature. The intended use must trace to one primary predicate. Mixing intended use from one device and technology from another, a split predicate, is discouraged and frequently leads to a Not Substantially Equivalent finding.
Without a valid predicate, the 510(k) pathway is closed. A low-risk to moderate-risk device with no predicate can pursue the De Novo classification request, which creates a new classification and can later become a predicate itself. Higher-risk devices generally require Premarket Approval (PMA) with clinical evidence rather than a substantial equivalence argument.
No. The predicate can be any legally marketed device, regardless of manufacturer. Submitters routinely cite competitor devices as predicates. You do not need permission from the predicate’s manufacturer, since the comparison relies on publicly available clearance information and the device’s established intended use and characteristics.
